Question 1

What is Ligand Pharmaceuticals?

Accepted Answer

Ligand Pharmaceuticals is a Company.

Question 2

How often does Ligand Pharmaceuticals appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 13 articles.

Question 3

When was Ligand Pharmaceuticals first tracked by Ergen?

Accepted Answer

First tracked on Apr 13, 2026.

Question 4

When was Ligand Pharmaceuticals last mentioned in news?

Accepted Answer

Last active on Jul 14, 2026.

Question 5

What is Ligand Pharmaceuticals's current news sentiment?

Accepted Answer

Aggregate sentiment score: 35 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Ligand Pharmaceuticals in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving Ligand Pharmaceuticals?

Accepted Answer

Ligand acquires XOMA Royalty (Jul 14, 2026, 6 articles).

Question 8

How did the "Ligand acquires XOMA Royalty" event impact Ligand Pharmaceuticals?

Accepted Answer

Acquired XOMA Royalty, expanding royalty portfolio; raised 2026 guidance; expects accretion.

Question 9

How did the "XOMA Royalty Declares Dividends, Redeems Preferred Stock" event impact Ligand Pharmaceuticals?

Accepted Answer

Ligand Pharmaceuticals Incorporated is acquiring XOMA Corporation through its subsidiary, Auddia Merger Sub, Inc. This event is a step towards the completion of the acquisition.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.